http://www.ncats.nih.gov/news-and-events/e-news/vol02-iss03/aug2013.html?utm_source=E-Newsletter&utm_campaign=4bfe95a788-May_17_Newsletter05_17_2013&utm_medium=email&utm_term=0_d32fa404b4-4bfe95a788-19346777#exrna
NCATS Supports Research on Newly Discovered Type of Cell-to-Cell Communication
On August 13, NIH announced $17 million in awards for the Extracellular RNA (exRNA) Communication program. This trans-NIH initiative is designed to advance research in a newly discovered type of cell-to-cell communication that may play a role in the diagnosis and treatment of various health conditions.Through 24 awarded research projects, scientists will explore basic exRNA biology and develop tools and technologies that apply new knowledge about exRNA to the research, diagnosis and treatment of diseases, including many types of cancer, bone marrow disorders, heart disease, Alzheimer’s disease and multiple sclerosis. NCATS will administer 18 of these awards, through which researchers will develop biomarkers from exRNA and design new ways to use exRNA in treatments.
The program is supported by the NIH Common Fund and led by a trans-NIH team that includes NCATS; the National Cancer Institute; the National Heart, Lung, and Blood Institute; the National Institute on Drug Abuse; and the National Institute of Neurological Disorders and Stroke.
Read the full news release to learn more. See the NCATS-administered projects on our website or view the complete list of awards on the NIH Common Fund website.
No comments:
Post a Comment